Form 4: Twist Bioscience Officer Sells Shares for Tax Obligations

Twist Bioscience Senior VP Dennis Cho sold 844 shares of common stock to cover tax withholding obligations related to Restricted Stock Unit vesting.

Summary

• Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary of Twist Bioscience Corp (TWST), reported a transaction.
• On February 23, 2026, Cho sold 844 shares of common stock at a price of $46.7098 per share.
• This sale was a 'sell to cover' transaction, mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units.
• The transaction does not represent a discretionary trade by the Reporting Person.
• Following this transaction, Dennis Cho beneficially owns 138,682 shares of Twist Bioscience common stock.
• The reported beneficial ownership includes shares acquired under the Issuer's Employee Stock Purchase Plan, which are exempt under Rule 16b-3(d) and Rule 16b-3(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a mandatory 'sell to cover' for tax obligations, not a discretionary sale, and therefore does not reflect a change in insider sentiment or company performance.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are a common and routine occurrence for executives receiving equity compensation. They are typically not indicative of an insider's sentiment towards the company's future prospects, unlike discretionary sales.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in company fundamentals or insider confidence.

Key Dates

Keywords

Twist Bioscience, TWST, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding, Sell to Cover, Corporate Officer